BACKGROUND: The accumulation of macrophages in inflamed atherosclerotic plaques has long been recognized. In an attempt to develop an imaging agent for detection of vulnerable plaques, we evaluated the feasibility of a liposomal-iodine nanoparticle contrast agent for computed tomography imaging of macrophage-rich atherosclerotic plaques in a mouse model. METHODS AND RESULTS: Liposomal-iodine formulations varying in particle size and polyethylene glycol coating were fabricated and shown to stably encapsulate the iodine compound. In vitro uptake studies using optical and computed tomography imaging in the RAW 264.7 macrophage cell line identified the formulation that promoted maximal uptake. Dual-energy computed tomography imaging using this formulation in apolipoprotein E-deficient (ApoE(-/-)) mice (n=8) and control C57BL/6 mice (n=6) followed by spectral decomposition of the dual-energy images enabled imaging of the liposomes localized in the plaque. Imaging cytometry confirmed the presence of liposomes in the plaque and their colocalization with a small fraction (≈2%) of the macrophages in the plaque. CONCLUSIONS: The results demonstrate the feasibility of imaging macrophage-rich atherosclerotic plaques using a liposomal-iodine nanoparticle contrast agent and dual-energy computed tomography.
BACKGROUND: The accumulation of macrophages in inflamed atherosclerotic plaques has long been recognized. In an attempt to develop an imaging agent for detection of vulnerable plaques, we evaluated the feasibility of a liposomal-iodine nanoparticle contrast agent for computed tomography imaging of macrophage-rich atherosclerotic plaques in a mouse model. METHODS AND RESULTS: Liposomal-iodine formulations varying in particle size and polyethylene glycol coating were fabricated and shown to stably encapsulate the iodine compound. In vitro uptake studies using optical and computed tomography imaging in the RAW 264.7 macrophage cell line identified the formulation that promoted maximal uptake. Dual-energy computed tomography imaging using this formulation in apolipoprotein E-deficient (ApoE(-/-)) mice (n=8) and control C57BL/6 mice (n=6) followed by spectral decomposition of the dual-energy images enabled imaging of the liposomes localized in the plaque. Imaging cytometry confirmed the presence of liposomes in the plaque and their colocalization with a small fraction (≈2%) of the macrophages in the plaque. CONCLUSIONS: The results demonstrate the feasibility of imaging macrophage-rich atherosclerotic plaques using a liposomal-iodine nanoparticle contrast agent and dual-energy computed tomography.
Authors: David S Alberts; Franco M Muggia; James Carmichael; Eric P Winer; Mohammad Jahanzeb; Alan P Venook; Keith M Skubitz; Edgardo Rivera; Joseph A Sparano; Nicholas J DiBella; Simon J Stewart; John J Kavanagh; Alberto A Gabizon Journal: Semin Oncol Date: 2004-12 Impact factor: 4.929
Authors: David P Cormode; Ewald Roessl; Axel Thran; Torjus Skajaa; Ronald E Gordon; Jens-Peter Schlomka; Valentin Fuster; Edward A Fisher; Willem J M Mulder; Roland Proksa; Zahi A Fayad Journal: Radiology Date: 2010-07-28 Impact factor: 11.105
Authors: Jiqiu Chen; Ching-Hsuan Tung; Umar Mahmood; Vasilis Ntziachristos; Robert Gyurko; Mark C Fishman; Paul L Huang; Ralph Weissleder Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson Journal: Circulation Date: 2003-10-07 Impact factor: 29.690
Authors: Dipanjan Pan; Todd A Williams; Angana Senpan; John S Allen; Mike J Scott; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza Journal: J Am Chem Soc Date: 2009-10-28 Impact factor: 15.419
Authors: Lotte E J R Schyns; Isabel P Almeida; Stefan J van Hoof; Benedicte Descamps; Christian Vanhove; Guillaume Landry; Patrick V Granton; Frank Verhaegen Journal: Br J Radiol Date: 2016-11-02 Impact factor: 3.039
Authors: Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus Journal: Adv Drug Deliv Rev Date: 2016-09-09 Impact factor: 15.470
Authors: David L Raunig; Lisa M McShane; Gene Pennello; Constantine Gatsonis; Paul L Carson; James T Voyvodic; Richard L Wahl; Brenda F Kurland; Adam J Schwarz; Mithat Gönen; Gudrun Zahlmann; Marina V Kondratovich; Kevin O'Donnell; Nicholas Petrick; Patricia E Cole; Brian Garra; Daniel C Sullivan Journal: Stat Methods Med Res Date: 2014-06-11 Impact factor: 3.021